Cite

HARVARD Citation

    Maity, A. et al. (2018). A phase I trial of pembrolizumab with hypofractionated radiotherapy in patients with metastatic solid tumours. British journal of cancer. 119 (10), pp. 1200-1207. [Online]. 
  
Back to record